Ipca Laboratories

Global Fund stops sourcing IPCA's anti-malaria drug

08 Apr 2016

Ipca to make open offer for 26% stake in Krebs on 9 November

04 Nov 2015

Canadian regulator asks Ipca to stop API exports

22 Sep 2014

Ipca Labs looks to acquire pharma unit in Indonesia

28 Sep 2011

Ipca Labs buys UK-based Onyx Research Chemicals

09 Aug 2011

Ipca Labs, US-based Heritage to market cardiovascular tablet, Propranolol in the US

13 Oct 2008

Ipca''s anti-malarial product Artesunate pre-qualified by WHO

By | 15 Sep 2007

Ipca-Ranbaxy alliance to market Metformin HCL tablets in US

14 Aug 2007

Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets

By | 02 Jan 2007

Ipca's 'Atenolol' bulk drug registered in China

29 Dec 2006

IPCA phases out single ingredient malarial drug; launches India's first ACT

By Our Corporate Bureau | 06 Oct 2006

Ipca Laboratories in marketing alliance with Ranbaxy for US sales

By | 21 Sep 2006

Ipca launches India's first novel injectible antibiotic combination

By Our Corporate Bureau | 20 May 2004